Skip to content

Interaction Between Antihypertensives and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Relevance of the Interaction Between Antihypertensive and Antirheumatic Drugs in a Family Practice

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00631514
Enrollment
88
Registered
2008-03-07
Start date
2005-01-31
Completion date
2006-09-30
Last updated
2008-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

antihypertensive drugs, non-steroidal anti-inflammatory drugs, interaction, family practice, arterial blood pressure

Brief summary

NSAIDs may increase blood pressure and blunt the effects of many antihypertensives. Members of these drug classes differ in their propensity to such an interaction.

Detailed description

To compare prospectively the effects of piroxicam, ibuprofen and acetaminophen on blood pressure control in hypertensive patients with osteoarthritis.

Interventions

DRUGacetaminophen

acetaminophen 1000 mg t.i.d. per os ibuprofen 400-600 mg t.i.d. per os piroxicam 10-20 mg o.d. per os

DRUGibuprofen

acetaminophen 1000 mg t.i.d. per os ibuprofen 400-600 mg t.i.d. per os piroxicam 10-20 mg o.d. per os

acetaminophen 1000 mg t.i.d. per os ibuprofen 400-600 mg t.i.d. per os piroxicam 10-20 mg o.d. per os

Sponsors

Dr Ivancica Pavlicevic Family Practice Office
CollaboratorUNKNOWN
University of Split
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
55 Years to 78 Years
Healthy volunteers
No

Inclusion criteria

* Treated hypertensives of either gender aged between 55 and 76 years * About 50% with concomitant osteoarthritis of the hip or knee

Exclusion criteria

* Normotensive persons or untreated hypertensives * Individuals outside the age limits * General

Design outcomes

Primary

MeasureTime frame
Arterial blood pressure3 months (3 individual blocks of 1 month each)

Secondary

MeasureTime frame
Body weight,serum electrolytes, urinary electrolytes (Na, K)3 months (3 periods of 1 month)

Countries

Croatia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026